MAT2A 抑制了 miR-26b-5p 调节的骨髓瘤进展中的铁化
Shuchi Xia1, Yun Liang2, Yuqing Shen1
1Department of Dentistry, Zhongshan Hospital Fudan University, Shanghai 200032, China.
Journal of bone oncology
|July 17, 2023
概括
抑制甲氨基基转移酶IIα (MAT2A) 通过影响STAT3/SLC7A11通路,引发骨肉瘤 (OS) 细胞中的铁亡. 这揭示了一个由MAT2A介导的防御机制,并建议OS的新铁灭诱导治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞死亡研究 细胞死亡研究
- 分子生物学分子生物学
背景情况:
- 骨髓瘤 (OS) 是最常见的原发性恶性骨瘤.
- 铁亡,一个调节的细胞死亡,对于瘤抑制至关重要.
- 甲氨基基转移酶IIα (MAT2A) 在OS铁亡中的作用尚不清楚.
研究的目的:
- 为了研究MAT2A在骨髓瘤 (OS) 细胞ferroptosis中的作用.
- 探索MAT2A在OS进展中的调控机制.
- 评估MAT2A作为OS的潜在治疗标.
主要方法:
- 细胞活力,细胞亡,细胞循环和迁移试验 (CCK-8,流细胞计,Transwell).
- 测量细胞内铁和谷氨 (GSH) 的水平.
- 对MAT2A,p-STAT3/STAT3和SLC7A11蛋白质表达的西部斑点分析.
- 在体内瘤进展研究和shRNA介导的MAT2A敲击.
主要成果:
- 在OS标本中,MAT2A被上调,并与预后不佳有关.
- MAT2A倒置增加了OS细胞的亡,诱导了G2细胞周期的停止,并减少了迁移.
- 在体内,MAT2A的枯竭抑制了OS瘤的生长,并促进了铁亡.
- 该miR-26b-5p/MAT2A轴通过STAT3/SLC7A11途径调节OS进展和铁亡.
结论:
- MAT2A促进OS的进展,并抑制铁亡.
- 通过增加铁素和抑制STAT3/SLC7A11轴,MAT2A倒置诱导OS细胞铁.
- 向MAT2A代表了骨髓瘤潜在的诱导铁亡的治疗策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


